FDA advisory panel votes AGAINST Covid-19 boosters for general population, but may yet approve it for elderly

The Food and Drug Administration’s (FDA) vaccine committee has voted against authorizing booster doses of Pfizer’s Covid-19 jab, stating that more data on the shot’s efficacy is needed.The agency's Vaccines and Related Biological Products Advisory Committee met on Friday and heard arguments from scientists and Pfizer representatives in favor of authorizing a third dose of the US drugmaker’s Covid-19 vaccine for the general public. After several hours of deliberation, the